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Caloric restriction (CR) is known to effectively elongate mammalian life-spans. The compound 2-
deoxy-D-glucose (2DG), which is often used as an inhibitor of glucose utilization, is a mimetic agent
of CR. In this study, we examined the changes of telomerase and Werner’s syndrome RecQ (WRN)
helicase after treatment with 2DG, because of the involvement of recQ helicase in the regulation
of telomeres. Interestingly, 2DG treatment increased the expression of WRN protein in accordance
with induction of its promoter activity and gene expression. Furthermore, the activation of telome-
rase was observed after 2DG treatment, whereas it resulted in the reduction of cell proliferation.
These results suggest that 2DG could up-regulate telomere maintenance factors accompanied with
suppression of proliferation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction associated with defects in RecQ helicase genes are known andSome of the protein factors that affect cellular senescence are
associated with genome stability, especially telomere maintenance
[1]. Telomeres are composed of short G-rich DNA repeat complexes
with various proteins [2]. Telomerase, which extends the G-rich
strand of telomeric DNA, is a ribonucleoprotein complex composed
of telomerase reverse transcriptase (TERT) and telomerase RNA
(TR) [3,4]. Shortened telomeres are known to limit proliferative life
span, but the telomerase supplies enough genetic stability for cells
to proliferate persistently.
DNA helicases play important roles in DNA replication, recom-
bination, repair, and transcription, by unwinding the duplex DNA
[5,6]. Among them, RecQ DNA helicases play important roles in
maintenance of genome stability [7–9]. Several human diseaseschemical Societies. Published by E
restriction; 2DG, 2-deoxy-D-
l-2-yl)-2,5-diphenyltetrazoli-
erase chain reaction; TERT,
ampliﬁcation protocol; WS,
umi).include Bloom’s syndrome (BS), Werner’s syndrome (WS) and
Rothmund–Thomson syndrome (RTS). Each of these can lead to
cancer or premature aging [10–12]. These premature aging syn-
dromes are associated with shortened telomeres [13]. Importantly,
Werner’s syndrome RecQ (WRN) helicase regulate telomeres by
affecting replication of G-rich telomeric DNA [10].
The compound 2-deoxy-D-glucose (2DG) is a potent inhibitor of
glucose metabolism thought to mimic glucose deprivation in vivo
that mimetic caloric restriction (CR) [14]. It is well known that
the CR extends life spans of various animals [14]. In this study,
tests are conducted to determine the effect of 2DG on telomere
maintenance factors, telomerase and WRN helicase to elucidate
whether 2DG is suitable for further research and development as
a treatment to protect telomeres.
2. Materials and methods
2.1. Cell culture
Human cervical carcinoma (HeLa S3) cells were grown in
Dulbecco’s modiﬁed Eagle’s (DME) medium (Nacarai, Tokyo,lsevier B.V. All rights reserved.
Table 2
Primers used for amplifying human cDNAs.
cDNA Name Sequence
BLM hBLM-S0057 50-GGATCCTGGTTCCGTCCGC-30
hBLM-A0764 50-CCTCAGTCAAATCTATTTGCTCG-30
HELB HDHB-S1046 50-GATATTGGTGTGGTGACA-30
HDHB-A1451 50-CACTTATGACTGTCACAGG-30
WRN hWRN-S2646 50-GGATCAGCACAGTCAGAAAATGTTCT-30
hWRN-A3158 50-GGATAGATTCAGTTTCCTAAGTTCACC-30
Sp1 hSp1-2487 50-CCATACCCCTTAACCCCG-30
AhSp1-2673 50-GAATTTTCACTAATGTTTCCCACC-30
b-actin hbactS541 50-TGACGGGGTCACCCACACTGTGCCCATC-30
hbactA1201 50-CTAGAAGCATTTGCGGTGGACGATGGAG-30
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Chemical, Tokyo, Japan) and penicillin–streptomycin at 37 C in a
humidiﬁed atmosphere with 5% CO2.
2.2. Cell viability assay [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay]
MTT assay was performed as described elsewhere [15]. In brief,
cells were cultured in a well of microtiter plate. Ten micro litter of
MTT/PBS solution (Wako Chemicals, Tokyo, Japan) was added to
each well (containing 100 ll of cell culture) and incubated 4 h in
a 37 C, 5% CO2 humidiﬁed incubator. Then, 100 ll of 0.04 N HCl
in 2-propanol was added, and the dark blue crystals were dissolved
completely. The absorbance of 570 nm was measured by a micro-
titer plate reader (Thermo electron Corp., Vantaa, Finland) and nor-
malized by the absorbance of 630 nm.
2.3. Construction of luciferase (Luc)-reporter plasmids
Luc reporter plasmids carrying the human WRN, BLM, HELB,
TERT, and p21 promoter regions were constructed as previously de-
scribed [16]. The 50-ﬂanking regions of these genes were obtained
by PCR with PrimeStar Taq polymerase (Takara, Kyoto, Japan) and
genomic DNA as a template. The primer-sets and template DNAs
used for PCR are shown in Table 1. The resultant plasmids were
designated pGL4-BLM, pGL4-HELB, pGL4-WRN, pGL4-TERT, and
pGL4-p21. The nucleotide sequences of the PCR products were
determined by a DNA Sequencing System (Applied Biosystems,
Foster City, CA) with Rv (50-TAGCAAAATAGGCTGTCCCC-30) and
GL (50-CTTTATGTTTTTGGCGTCTTCC-30) primers.
2.4. Transient transfection and Luc assays
Plasmid DNAs were transfected into HeLa S3 cells by the DEAE-
dextran method [16]. After 24 h of transfection, 2DG was added to
the culture medium. After a further 24 h of incubation, cells were
collected and lysed with 100 ll of 1 Cell culture lysis reagent,
mixed, and centrifuged at 12000g for 5 s. The supernatant was
stored at 80 C. Luc and Dual-Luc assays were performed with
the Luc assay system and with the Dual-Luc assay system (Prome-
ga, Madison, WI), respectively, as described previously [16].
2.5. Reverse transcriptase polymerase chain reaction (RT-PCR)
RT-PCR was carried out as described previously [17]. First-
strand cDNAs were synthesized with Rever Tra Ace (Toyobo, Tokyo,
Japan), random primers (Takara), and total RNAs extracted from
HeLa S3 cells. Primer pairs to amplify human BLM, HELB, WRN,
Sp1, and b-actin cDNAs are listed in Table 2. The conditions for
PCR were as follows: 94 C 30 s, 55 C 30 s, and 72 C 1 min, with
27 (BLM), 26 (WRN and HELB), 22 (Sp1), and 20 (b-actin) cycles.Table 1
Primers used for amplifying 50-upstream regions of human genes.
Promoter Accession no. Name
BLM NW925940.1 ShBLM-88
AhBLM-8
HELB NW925395.1 ShDHB-6
AhDHB-6
WRN NW923907.1 ShWRN-6
AhWRN-6
TERT NW922518.1 ShTERT-4
AhTERT-4
p21 NW923073.1 Shp21-96
Ahp21-96The PCR products were electrophoresed on 5% acrylamide gel
and stained with ethidium bromide.
2.6. Quantitative real-time PCR
Real time PCR analysis was carried out using the Mx3000P Real-
Time QPCR System (Stratagene, La Jolla, CA) as described previ-
ously [18,19]. For PCR ampliﬁcation, cDNAs were ampliﬁed using
SYBR Green Realtime PCR Master Mix (Toyobo) and 0.4 lM of each
primer pair. Ampliﬁcation was carried out starting with an initial
step for 30 s at 94 C, followed by 40 cycles (94 C 30 s, 55 C
30 s, and 72 C 1 min). Quantitative PCR analysis for each sample
was carried out in triplicates. Relative gene expression values were
obtained by normalizing CT (threshold cycle) values of the target
genes in comparison with CT values of the BLM gene using the
DDCT method.
2.7. Western blot analysis
Western blot analysis was carried out as previously described
[16] with antibodies against WRN (Santa Cruz Biotechnology,
Santa Cruz, CA), and BLM (Calbiochem, Darmstadt, Germany) fol-
lowed by the addition of horseradish peroxidase (HRP)-conjugated
secondary antibody (Calbiochem). Signal intensities were quanti-
ﬁed with Image Gangue Software (Fuji Film, Tokyo, Japan).
2.8. Telomerase ampliﬁcation protocol (TRAP) assay
Cell pellets (3  105) were treated with 200 ll of ice-cold 1
CHAPS lysis buffer (10 mM Tris–HCl [pH 7.5], 1 mM MgCl2, 1 mM
EGTA, 0.1 mM benzamidine, 5 mM b-mercaptoethanol, 0.5%
CHAPS, and 10% glycerol), incubated on ice for 30 min, and centri-
fuged at 12000g for 20 min at 4 C. The supernatant was then
stored at 80 C. TRAP assays were performed with a TRAP assay
kit (Chemicon, Temecula, CA) as described previously [20]. SignalSequence
534 50-GATATCGGTACCATGGTTTCTCACGTGTCCATG-30
9145 50-GATATCTCGAGACTCCTAGCGGACGGAACCAGG-30
9026 50-TCGGTACCAAGACTTTCAAGTACCATCCTC-30
8161 50-ATCTCGAGCAGAGGTCCCTGAAGTTGGCGC-30
4784 50-TCGGTACCTCTTCCTCAGTGCACTCTCTGACTG-30
5201 50-GATATCTCGAGTACAAGCCGGCGCCTCCCCGG-30
34754 50-TCGGTACCAGTGGATTCGCGGGCACAG-30
34491 50-ATCTCGAGGGCTTCCCACGTGCGCAGC-30
65569 50-TCGGTACCAGATTTGTGGCTCACTTCG-30
65883 50-ATCTCGAGGAACTGACTTCGGCAGCTGC-30
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quantiﬁed with Image Gangue Software (Fuji Film).
3. Results
3.1. Proliferation of HeLa S3 cells after 2DG-treatment
Because 2DG is known as a potent inhibitor of glucose metabo-
lism, we examined its effect on cell proliferation of HeLa S3 cells.
The viability of HeLa S3 cells after 2DG treatment was thus exam-
ined using an MTT assay. As shown in Fig. 1, proliferation was sup-
pressed by 2DG in a dose-dependent manner. In this experimental
condition, apoptotic cells were not observed after 24 h treatment
with 8 mM 2DG addition, but the growth of the cells was greatly
attenuated.
3.2. WRN gene expression is augmented by 2DG
The WS phenotype shows the symptoms of premature aging
with genomic instability, an elevated risk of malignancy and accel-
erated cellular senescence [21]. It has been shown that RecQ heli-
case, WRN is required for efﬁcient lagging-strand replication of G-
rich telomeric DNA [10]. To investigate WRN and other gene
expressions after 2DG treatment, RT-PCR analysis was performed
(Fig. 2A). Quantitative real time PCR indicated that the expression
of the WRN gene increased gradually during treatment with 8 mM
2DG in a time dependent manner (Fig. 2B). On the other hand,
Bloom’s syndrome RecQ helicase (BLM) gene expression was not
changed (Fig. 2A). The human DNA helicase B, HELB (HDHB) is a
RecD like helicase and has been suggested to be critical for the
G1/S transition of the cell cycle and to participate in DNA damage
response [22]. Similar to the WRN, HELB gene expression was
shown to increase at 8–24 h after 2DG addition (Fig. 2B).
BecauseWRN gene expression positively responded to 2DG, fur-
ther examination was undertaken to determine whether WRN
transcripts are accumulated by increasing the 2DG concentration
in the culture medium. As shown in Fig. 2C, the WRN gene expres-
sion was up-regulated by 2DG when the cells were treated with 6–
10 mM of 2DG.
3.3. Effect of 2DG on the WRN promoter
In order to examine if promoter activities of human WRN, BLM,
and HELB genes are affected by the 2DG treatment, 50-ﬂanking
regions of these genes isolated by PCR were subcloned into aFig. 1. 2DG treatment reduces proliferation of HeLa S3 cells. HeLa S3 cells were
treated with 2DG (1–10 mM) for 24 h. Results represent cell viability measured by
MTT assay. The results show the mean ± S.D. of four independent experiments.
Fig. 2. Changes in gene expressions of various DNA helicases after 2DG treatment.
(A) HeLa S3 cells were treated with 2DG (8 mM) for 0, 2, 4, 6, 8, and 24 h (lanes 1–6,
respectively). Total RNAs were extracted from the cells, and synthesized cDNAs
were subjected to PCR with appropriate primer pairs to amplify WRN, BLM, HELB,
and b-actin cDNA. (B) HeLa S3 cells were treated with 2DG (8 mM) for 0, 8 and 24 h.
Realtime PCR analysis was performed with cDNA prepared from similar experi-
mental conditions as described above. Results show relative gene expressions of
WRN (diamonds), Sp1 (squares), and HELB (triangles) compared with that of BLM.
The results show the mean ± S.D. of three independent assays. (C) Realtime RT-PCR
was carried out to analyzeWRN and BLM gene expression in HeLa S3 cells after 0, 1,
2, 4, 6, 8, and 10 mM of 2DG treatment for 24 h. Histograms show relativeWRN/BLM
gene expression ratio compared with that of 2DG-non-treated cells. The results
show the mean ± S.D. of four independent experiments. Signiﬁcance of differences
between control (0 h) and 2DG treated cells were analyzed by Student’s t-test
(*P < 0.05, **P < 0.01, and ***P < 0.005).multi-cloning site of the pGL4-basic vector. No obvious TATA or
CCAAT-boxes were found in these regions (Fig. 3A). Interestingly,
putative GC-boxes or Sp1 binding elements are commonly found
in theWRN, BLM, and HELB promoters. The Luc-reporter constructs
were transfected into HeLa S3 cells and they were treated with
8 mM 2DG for 24 h. Because amounts of the BLM transcript were
not changed through 2DG treatment (Fig. 2A), Luc activities of
Fig. 3. Effect of 2DG on promoter activities of the WRN, BLM, and HELB genes. (A) Schematic diagrams of 50-ﬂanking regions of the human WRN, BLM, HELB, TERT, and p21
genes, which were sub-cloned into pGL4-basic vector, are shown. (B) HeLa S3 cells were transiently transfected with pGL4-BLM (columns 1 and 2), pGL4-WRN (columns 3 and
4), pGL4-HELB (columns 5 and 6), pGL4-hTERT (columns 7 and 8), and pGL4-p21 (columns 9 and 10). After 24 h incubation, cells were treated with 2DG (10 mM) for 24 h.
Results show relative Luc activities of these reporter plasmid-transfected cells compared with that of pGL4-BLM vector transfected cells. Results show the mean ± S.D. of four
independent assays. Signiﬁcance of differences between control (2DG-) and 2DG treated cells were analyzed by Student’s t-test (*P < 0.01, **P < 0.005). (C) HeLa S3 cells were
transiently transfected with pGL4-WRN or pGL4-BLM and treated with 0–8 mM of 2DG. After 24 h incubation, cells were harvested and dual-Luc assays were performed.
Results show relative Luc activities of these reporter plasmid-transfected cells compared with that of pGL4-BLM vector transfected cells. Results show the mean ± S.D. of six
independent assays. Signiﬁcance of differences between control (0 mM) and 2DG treated cells were analyzed by Student’s t-test (*P < 0.01, **P < 0.005).
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cells were compared with the Luc activity of the pGL4-BLM trans-
fected cells (Fig. 3B). Interestingly, the WRN/BLM promoter activity
ratio increased from 3 to 12 with the 2DG treatment. Similarly,
HELB/BLM, TERT/BLM, and p21/BLM promoter activity ratios in-
creased from 1 to 3, from 3 to 6, and from 0.5 to 1, respectively.
As shown in Fig. 3C, the dose-dependent proﬁle of the WRN/BLM
promoter activity ratio is similar to that of the relative WRN gene
expression (Fig. 2C).
3.4. Expression of WRN protein after 2DG treatment
The data above indicated thatWRN gene expression and its pro-
moter activity increased in response to treatment with 2DG. As a
consequence, an examination of WRN protein expression by Wes-
tern blotting with samples from cells treated with 8 mM of 2DG
was undertaken. As shown in Fig. 4A and B, WRN/BLM expression
ratio was augmented after 8–24 h 2DG treatment.
3.5. Telomerase is activated by 2DG treatment
In order to examine the effect of 2DG on telomerase activity, a
TRAP assay was performed with the protein sample from HeLa
S3 cells treated with various concentrations of 2DG. As shown in
Fig. 4C and D, telomerase activity responded to 2DG dose-depen-
dently. The highest telomerase activity was observed when cells
were treated with 10 mM of 2DG (Fig. 4C, lane 6).
4. Discussion
Dysfunctions of the RecQ DNA helicase family are known to be
responsible for tumorigenesis and premature aging [23]. The hu-
man RecQ DNA helicase gene family has ﬁve members, RecQ1,BLM, WRN, RecQ4, and RecQ5. Mutations in the WRN gene give rise
to WS, which is associated at a relatively early age with many of
the features of the normal aging process [24]. The BLM gene is mu-
tated in BS, a rare disorder associated with pleiotropic phenotypes
including immunodeﬁciency and impaired fertility [25]. In addi-
tion, WRN and BLM helicases are suggested to regulate mamma-
lian telomeres [9]. In this study, the effects of 2DG on the gene/
protein expressions of RecQ helicases and telomerase were inves-
tigated. Interestingly, telomerase was most notably activated by
treatment with 10 mM of 2DG in accordance with the activation
of the WRN promoter and its gene expression. Given that WRN
helicase functions to resolve G-rich cap structures of telomeres
during DNA replication [10], cooperative induction of the WRN
helicase and telomerase might be beneﬁcial for cells to maintain
telomeres properly.
2DG is a sugar analogue with a limited metabolism that reduces
the glucose/energy ﬂux without reducing food intake and is
thought to elicit the same beneﬁcial effects as CR [14]. Thus, 2DG
is thought to mimic glucose deprivation in vivo or CR to reduce
the amount of oxidative by products metabolizing fewer calories
[26]. CR is the only intervention conclusively and reproducibly
shown to slow aging and maintain health and vitality in mammals
[14]. Furthermore, it was shown that CR reduces the cell prolifera-
tion rate in various rodent tissues [27]. Therefore, glucose depriva-
tion by 2DG could reduce proliferation of cells.
The WRN promoter responded to 2DG treatment (Fig. 3), and
the WRN gene/protein expressions were augmented by the 2DG
treatment (Figs. 2 and 4). This might have come from GC-box/
Sp1 elements in the WRN promoter (Fig. 3A). The magnitude of
the response to 2DG increases according with the numbers of the
GC-box/Sp1 elements in the 50-upstream regions of these genes.
Moreover, Sp1 gene expression was induced after 2DG-treatment
(Fig. 2B), suggesting thatWRN, HELB, TERT, and p21 promoters were
Fig. 4. 2DG treatment induces WRN protein expression and telomerase activity in HeLa S3 cells. (A) HeLa S3 cells were treated with 2DG (8 mM) for 0 (lanes 1 and 2), 4 (lanes
3–5), 8 (lanes 6–8), and 24 h (lanes 9–11). Proteins extracted from 2DG-treated cells (7.5  104) were separated by a 7.5% SDS–polyacrylamide gel electrophoresis, and
Western blotting was performed with anti-WRN and anti-BLM antibodies (upper and lower panels, respectively). (B) Each band was quantiﬁed and results show relative
WRN/BLM protein expression ratio compared with that of the 2DG-non-treated cells. Signiﬁcance of differences between control (0 h) and 2DG treated cells were analyzed by
Student’s t-test (*P < 0.005). (C) Effect of 2DG on telomerase activity in HeLa S3 cells. CHAPS lysis buffer extracts (20 ng) from HeLa S3 cells were analyzed by TRAP assay. HeLa
S3 cells were treated with the indicated concentrations of 2DG (0–10 mM) for 24 h (lanes 1–14). Lanes 8–14 represent backgrounds with samples that were incubated at
85 C for 10 min. 1 CHAPS (lane 15) and TSR8 (lane 16) represent negative and positive controls, respectively. (D) Signal intensities of TRAP-products and internal controls
were quantiﬁed and telomerase activities were calculated as described in the manufacturer’s protocol. Histograms show relative telomerase activities compared with 2DG-
non-treated cells. Results show the mean ± S.D. of three independent assays. Signiﬁcance of differences between control (0 h) and 2DG treated cells were analyzed by
Student’s t-test (*P < 0.05).
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1336 B. Zhou et al. / FEBS Letters 583 (2009) 1331–1336activated by Sp1 expression. It has been reported that 2DG induces
c-fos and dopamine-b-hydroxylase (DBH) genes in speciﬁc neurons
in the brain of rats [28,29]. Therefore, it is possible that transcrip-
tional conditions in the cells are altered by the 2DG treatment.
This suggestion, however, requires further investigation to be
conﬁrmed.
As a CR mimetic drug, 2DG has a very narrow therapeutic range
bordering on toxicity and thus eliminating it as a drug candidate
for human beings [14]. If 2DG or its derivatives are further im-
proved to have lower levels of toxicity, it will contribute to protect
chromosomes from damages by keeping cells with longer telo-
meres by inducing telomere maintenance factors.
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